SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Granules India - Quaterly Results

30 Jul 2024 Evaluate
The Total revenue for the quarter ended June 2024 of  Rs. 8519.50 millions remain, more or less, the same.A slim rise of 17.46% was recorded in the Net profit for the quarter ended June 2024 to Rs. 937.79  millions  From Rs. 798.40 millions.The company reported a good operating profit of 1792.23 millions compared to 1572.10 millions of corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202406 202306 % Var 202406 202306 % Var 202403 202303 % Var
Sales 8519.50 8210.00 3.77 8519.50 8210.00 3.77 37550.91 39312.00 -4.48
Other Income 18.08 4.36 314.68 18.08 4.36 314.68 57.77 99.32 -41.83
PBIDT 1792.23 1572.10 14.00 1792.23 1572.10 14.00 8071.37 8481.71 -4.84
Interest 175.17 147.88 18.45 175.17 147.88 18.45 719.98 386.74 86.17
PBDT 1617.06 1424.22 13.54 1617.06 1424.22 13.54 7351.39 8094.97 -9.19
Depreciation 358.47 352.67 1.64 358.47 352.67 1.64 1438.48 1455.57 -1.17
PBT 1258.59 1071.55 17.46 1258.59 1071.55 17.46 5912.91 6639.40 -10.94
TAX 320.80 273.15 17.44 320.80 273.15 17.44 1553.73 1651.55 -5.92
Deferred Tax 10.53 17.54 -39.97 10.53 17.54 -39.97 47.68 -50.51 -194.40
PAT 937.79 798.40 17.46 937.79 798.40 17.46 4359.18 4987.85 -12.60
Equity 242.37 242.04 0.14 242.37 242.04 0.14 242.37 242.04 0.14
PBIDTM(%) 21.04 19.15 9.86 21.04 19.15 9.86 21.49 21.58 -0.37

Granules India Share Price

654.40 3.60 (0.55%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×